Daiwa Securities Group’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.96M	Buy	11,341 +1,995	+21%	+$370K	0.01%	652
2025 Q4	$1.86M	Sell	9,346 -2,287	-20%	-$415K	0.01%	667
2025 Q3	$1.82M	Sell	11,633 -1,745	-13%	-$277K	0.01%	655
2025 Q2	$2.03M	Buy	13,378 +10,234	+326%	+$1.36M	0.01%	615
2025 Q1	$473K	Sell	3,144 -3,676	-54%	-$616K	﹤0.01%	835
2024 Q4	$1.26M	Buy	6,820 +465	+7%	+$89.6K	0.01%	685
2024 Q3	$1.25M	Buy	6,355 +710	+13%	+$148K	0.01%	689
2024 Q2	$1.17M	Buy	5,645 +582	+11%	+$132K	0.01%	677
2024 Q1	$1.37M	Buy	5,063 +514	+11%	+$123K	0.01%	648
2023 Q4	$1.07M	Buy	4,549 +265	+6%	+$52.1K	0.01%	682
2023 Q3	$840K	Buy	4,284 +266	+7%	+$54.6K	0.01%	717
2023 Q2	$845K	Buy	4,018 +211	+6%	+$42K	0.01%	700
2023 Q1	$768K	Buy	3,807 +200	+6%	+$45.3K	0.01%	717
2022 Q4	$786K	Buy	3,607 +200	+6%	+$43.7K	0.01%	707
2022 Q3	$670K	Buy	3,407 +178	+6%	+$38.4K	0.01%	737
2022 Q2	$691K	Buy	3,229 +28	+0.9%	+$6.84K	0.01%	753
2022 Q1	$909K	Buy	3,201 +192	+6%	+$59.2K	0.01%	725
2021 Q4	$1.13M	Buy	3,009 +174	+6%	+$67.6K	0.01%	672
2021 Q3	$1.17M	Buy	2,835 +56	+2%	+$23.3K	0.01%	633
2021 Q2	$1.03M	Buy	+2,779	New	+$928K	0.01%	631